Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
2261
-
2262
-
2263
Spearman correlation of age with proportions of cell types in men, for each brain region.
Published 2024Subjects: -
2264
-
2265
-
2266
-
2267
-
2268
-
2269
-
2270
Expression of proteins significantly correlated with stereotypy severity in CD1 Mice (n = 28).
Published 2025“…Expression of 7 proteins significantly correlated with stereotypy severity in CD1 mice. …”
-
2271
Changes in Mf (A and B) CFA (C and D) prevalence at baseline, 1, 2 and 3 years after starting MDA.
Published 2025Subjects: -
2272
-
2273
-
2274
Amplitude for A/L = 0.29.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2275
Amplitude for A/L = 0.338.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2276
Amplitude for A/L = 0.02.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2277
Amplitude for A/L = 0.03.
Published 2025“…By increasing the surface roughness of the bluff body, the lock-in region decreases and as a result, the harvested power from that bluff body is reduced. …”
-
2278
AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves.
Published 2025Subjects: -
2279
-
2280
Comparison in baseline variables between efficacy group and non-efficacy group.
Published 2025Subjects: